Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Viral Vector Purification Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vector Purification Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vector Purification Overall Market Size
2.1 Global Viral Vector Purification Market Size: 2022 VS 2029
2.2 Global Viral Vector Purification Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vector Purification Players in Global Market
3.2 Top Global Viral Vector Purification Companies Ranked by Revenue
3.3 Global Viral Vector Purification Revenue by Companies
3.4 Top 3 and Top 5 Viral Vector Purification Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral Vector Purification Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Vector Purification Players in Global Market
3.6.1 List of Global Tier 1 Viral Vector Purification Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vector Purification Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vector Purification Market Size Markets, 2022 & 2029
4.1.2 Retroviral Vectors
4.1.3 Vaccine Virus
4.1.4 Adenoviral Vectors
4.1.5 Adeno-Associated Viral Vectors
4.1.6 Lentivirus
4.1.7 Others
4.2 By Type - Global Viral Vector Purification Revenue & Forecasts
4.2.1 By Type - Global Viral Vector Purification Revenue, 2018-2023
4.2.2 By Type - Global Viral Vector Purification Revenue, 2024-2029
4.2.3 By Type - Global Viral Vector Purification Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vector Purification Market Size, 2022 & 2029
5.1.2 Gene Therapy
5.1.3 Cell Therapy
5.1.4 Vaccinology
5.2 By Application - Global Viral Vector Purification Revenue & Forecasts
5.2.1 By Application - Global Viral Vector Purification Revenue, 2018-2023
5.2.2 By Application - Global Viral Vector Purification Revenue, 2024-2029
5.2.3 By Application - Global Viral Vector Purification Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Viral Vector Purification Market Size, 2022 & 2029
6.2 By Region - Global Viral Vector Purification Revenue & Forecasts
6.2.1 By Region - Global Viral Vector Purification Revenue, 2018-2023
6.2.2 By Region - Global Viral Vector Purification Revenue, 2024-2029
6.2.3 By Region - Global Viral Vector Purification Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Viral Vector Purification Revenue, 2018-2029
6.3.2 US Viral Vector Purification Market Size, 2018-2029
6.3.3 Canada Viral Vector Purification Market Size, 2018-2029
6.3.4 Mexico Viral Vector Purification Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Viral Vector Purification Revenue, 2018-2029
6.4.2 Germany Viral Vector Purification Market Size, 2018-2029
6.4.3 France Viral Vector Purification Market Size, 2018-2029
6.4.4 U.K. Viral Vector Purification Market Size, 2018-2029
6.4.5 Italy Viral Vector Purification Market Size, 2018-2029
6.4.6 Russia Viral Vector Purification Market Size, 2018-2029
6.4.7 Nordic Countries Viral Vector Purification Market Size, 2018-2029
6.4.8 Benelux Viral Vector Purification Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Viral Vector Purification Revenue, 2018-2029
6.5.2 China Viral Vector Purification Market Size, 2018-2029
6.5.3 Japan Viral Vector Purification Market Size, 2018-2029
6.5.4 South Korea Viral Vector Purification Market Size, 2018-2029
6.5.5 Southeast Asia Viral Vector Purification Market Size, 2018-2029
6.5.6 India Viral Vector Purification Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Viral Vector Purification Revenue, 2018-2029
6.6.2 Brazil Viral Vector Purification Market Size, 2018-2029
6.6.3 Argentina Viral Vector Purification Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Vector Purification Revenue, 2018-2029
6.7.2 Turkey Viral Vector Purification Market Size, 2018-2029
6.7.3 Israel Viral Vector Purification Market Size, 2018-2029
6.7.4 Saudi Arabia Viral Vector Purification Market Size, 2018-2029
6.7.5 UAE Viral Vector Purification Market Size, 2018-2029
7 Viral Vector Purification Companies Profiles
7.1 Applied Biological Materials Inc.
7.1.1 Applied Biological Materials Inc. Company Summary
7.1.2 Applied Biological Materials Inc. Business Overview
7.1.3 Applied Biological Materials Inc. Viral Vector Purification Major Product Offerings
7.1.4 Applied Biological Materials Inc. Viral Vector Purification Revenue in Global Market (2018-2023)
7.1.5 Applied Biological Materials Inc. Key News & Latest Developments
7.2 Creative Biolabs
7.2.1 Creative Biolabs Company Summary
7.2.2 Creative Biolabs Business Overview
7.2.3 Creative Biolabs Viral Vector Purification Major Product Offerings
7.2.4 Creative Biolabs Viral Vector Purification Revenue in Global Market (2018-2023)
7.2.5 Creative Biolabs Key News & Latest Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Company Summary
7.3.2 Bio-Rad Laboratories, Inc. Business Overview
7.3.3 Bio-Rad Laboratories, Inc. Viral Vector Purification Major Product Offerings
7.3.4 Bio-Rad Laboratories, Inc. Viral Vector Purification Revenue in Global Market (2018-2023)
7.3.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.4 Sirion-Biotech GmbH
7.4.1 Sirion-Biotech GmbH Company Summary
7.4.2 Sirion-Biotech GmbH Business Overview
7.4.3 Sirion-Biotech GmbH Viral Vector Purification Major Product Offerings
7.4.4 Sirion-Biotech GmbH Viral Vector Purification Revenue in Global Market (2018-2023)
7.4.5 Sirion-Biotech GmbH Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Viral Vector Purification Major Product Offerings
7.5.4 Merck KGaA Viral Vector Purification Revenue in Global Market (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.6.3 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Major Product Offerings
7.6.4 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Revenue in Global Market (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.7 Batavia BiosciencesB.v.Agilent Technologies, Inc.
7.7.1 Batavia BiosciencesB.v.Agilent Technologies, Inc. Company Summary
7.7.2 Batavia BiosciencesB.v.Agilent Technologies, Inc. Business Overview
7.7.3 Batavia BiosciencesB.v.Agilent Technologies, Inc. Viral Vector Purification Major Product Offerings
7.7.4 Batavia BiosciencesB.v.Agilent Technologies, Inc. Viral Vector Purification Revenue in Global Market (2018-2023)
7.7.5 Batavia BiosciencesB.v.Agilent Technologies, Inc. Key News & Latest Developments
7.8 ProBioGen AG
7.8.1 ProBioGen AG Company Summary
7.8.2 ProBioGen AG Business Overview
7.8.3 ProBioGen AG Viral Vector Purification Major Product Offerings
7.8.4 ProBioGen AG Viral Vector Purification Revenue in Global Market (2018-2023)
7.8.5 ProBioGen AG Key News & Latest Developments
7.9 Takara Bio lnc.
7.9.1 Takara Bio lnc. Company Summary
7.9.2 Takara Bio lnc. Business Overview
7.9.3 Takara Bio lnc. Viral Vector Purification Major Product Offerings
7.9.4 Takara Bio lnc. Viral Vector Purification Revenue in Global Market (2018-2023)
7.9.5 Takara Bio lnc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer